BDBM721024 8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl)-7-fluoro-1-isopropyl-3-methyl-1H-imidazo[4,5-c]cinnolin-2(3H)-one::US12226414, Example 4

SMILES CC(C)n1c(=O)n(C)c2nnc3cc(F)c(-c4ccc(N5CCC(N(C)C)CC5)nc4)cc3c21

InChI Key InChIKey=GFGRHEYDSLFDPV-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 721024   

TargetSerine-protein kinase ATM(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 10nMAssay Description:ATM (Millipore, Cat. No. 14-933) enzyme solution was prepared in 1× kinase base buffer. 10 μl of 2× enzyme solution was transferred to each well of t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:Solution of mTOR enzymes (Millipore, Cat. No. 14-770, Lot. No. 2052551) was prepared in 1× kinase buffer at 4-fold of the final concentration (final ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:PI3Kα (p110α/p85a), PIK3C δ, PIK3Cβ (p110β), PIK3Cγ (pp110γ) kinase reaction solutions of PI3Kα (Invitrogen, Cat. No. PV4788), PIK3Cδ (Invitrogen, Ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent

TargetSerine/threonine-protein kinase ATR(Human)
Suzhou Zanrong Pharma

US Patent
LigandPNGBDBM721024(8-(6-(4-(dimethylamino)piperidin-1-yl)pyridin-3-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:ATR enzyme was made by ChemPartner (batch: CP-ATR-20161102-M2). 2× enzyme solutions were prepared in 1× kinase base buffer. 10 μl of 2× enzyme soluti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
US Patent